- Home
- LFWD
LFWD
REWALK ROBOTICS LTD
as 04-02-2025 4:00pm EST
Stocks
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
| Founded: | 2001 | Country: | Israel |
| Employees: | N/A | City: | MARLBOROUGH |
| Market Cap: | 18.6M | IPO Year: | 2014 |
| Target Price: | $9.00 | AVG Volume (30 days): | 5.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.25 - $6.00 | Next Earning Date: | 05-14-2025 |
| Revenue: | $25,663,000 | Revenue Growth: | 85.24% |
| Revenue Growth (this year): | 16.16% | Revenue Growth (next year): | 51.10% |
Stock Insider Trading Activity of REWALK ROBOTICS LTD (LFWD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Lind Global Fund II LP | LFWD | 10% Owner | Jan 6 '25 | Sell | $2.78 | 573,110 | $1,655,009.22 | 1,347,780 |
Latest REWALK ROBOTICS LTD News
LFWD Breaking Stock News: Dive into LFWD Ticker-Specific Updates for Smart Investing
GlobeNewswire
21 days ago
FDA Issues Clearance for ReWalk 7 Exoskeleton
GuruFocus.com
a month ago
Lifeward Ltd (LFWD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ...
GlobeNewswire
a month ago
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
a month ago
Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton
GlobeNewswire
a month ago
Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
GlobeNewswire
a month ago
Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025
GlobeNewswire
a month ago
Lifeward Announces CEO Transition
TipRanks
2 months ago
Lifeward finalizes agreement with BARMER
Compare LFWD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LFWD REWALK ROBOTICS LTD - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.